Use of Foscarnet Therapy for EBV Infection following Control of PTLD with Enhancement of Cellular Immunity in a Lung-Transplant Recipient
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication following solid organ transplantation with an annual incidence rate of 3–5% in lung-transplant recipients. Pathogenesis indicates a strong association with functional over-immunosuppression and EBV infection. Clinical impro...
Saved in:
| Main Authors: | Kamyar Afshar, A. Purush Rao, Vipul Patel, Kevin Forrester, Sivagini Ganesh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2011/919651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
by: Viola Menghi, et al.
Published: (2016-01-01) -
Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
by: Sofya Tokman, et al.
Published: (2016-01-01) -
A national survey of immunosuppression adjustment in elderly lung transplant recipients
by: Jade M Kozuch, et al.
Published: (2024-12-01) -
Variable EBV DNA Load Distributions and Heterogeneous EBV mRNA Expression Patterns in the Circulation of Solid Organ versus Stem Cell Transplant Recipients
by: A. E. Greijer, et al.
Published: (2012-01-01) -
Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant
by: Brian Cuzzo, et al.
Published: (2025-05-01)